The DOI matches its Crossref record; 46 of the 51 references it cites were found in a registry or an index, and 5 are not checked yet.
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Open accessAbstract
The AML-1/CBF beta transcription factor complex is targeted by both the t(8;21) and the inv(16) chromosomal alterations, which are frequently observed in acute myelogenous leukemia. AML-1 is a site-specific DNA-binding protein that recognizes the enhancer core motif TGTGGT. The t(8;21) translocation fuses the first 177 amino acids of AML-1 to MTG8 (also known as ETO), generating a chimeric protein that retains the DNA-binding domain of AML-1. Analysis of endogenous AML-1 DNA-binding complexes suggested the presence of at least two AML-1 isoforms. Accordingly, we screened a human B-cell cDNA library and isolated a larger, potentially alternatively spliced, form of AML1, termed AML1B. AML-1B is a protein of 53 kDa that binds to a consensus AML-1-binding site and complexes with CBF beta. Subcellular fractionation experiments demonstrated that both AML-1 and AML-1/ETO are efficiently extracted from the nucleus under ionic conditions but that AML-1B is localized to a salt-resistant nuclear compartment. Analysis of the transcriptional activities of AML-1, AML-1B, and AML-1/ETO demonstrated that only AML-1B activates transcription from the T-cell receptor beta enhancer. Mixing experiments indicated that AML-1/ETO can efficiently block AML-1B-dependent transcriptional activation, suggesting that the t(8;21) translocation creates a dominant interfering protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.229 · Cited by 3,485
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Multiple Point Mutations Affecting the Simian Virus 40 Enhancer
Weiher, H., König, M., & Gruß, P. (1983) · Science · doi:10.1126/science.6297005 · Cited by 803
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Berger, J., Hauber, J., Hauber, R., Geiger, R. E., & Cullen, B. R. (1988) · Gene · doi:10.1016/0378-1119(88)90219-3 · Cited by 667
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.Preprint
Hiebert, S. W., Chellappan, S., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Bae S.-C., 1994, Mol. Cell. Biol., 14, 3242
- Bae S. C., 1993, Oncogene, 8, 809
- Gottschalk L. R., 1990, Mol. Cell. Biol., 10, 5486
- Redondo J. M., 1991, Mol. Cell. Biol., 11, 5671
- Wang S., 1993, EMBO J., 13, 3324
Cited by
Sorted by citations
Items 301–367 of 367
The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1
Qadi, A. A., Taberlay, P. C., Phillips, J. L., Young, A., West, A. C., Brettingham‐Moore, K. H., Dickinson, J. L., & Holloway, A. F. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25246 · Cited by 11
Acute Myeloid Leukemia in Adults
Appelbaum, F. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50108-1 · Cited by 10
Stein, G. S., Stein, J. L., Lian, J. B., van Wijnen, A. J., Montecino, M. A., Javed, A., Zaidi, S. K., Young, D. W., Choi, J. Y., & Pockwinse, S. M. (2004) · PubMed · doi:10.4081/860 · Cited by 10
Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO
Hines, R., Boyapati, A., & Zhang, D. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.05.005 · Cited by 9
Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes
Szyrach, M., Münchberg, F. E., Riehle, H., Nordheim, A., Krauter, J., Nagel, S., Heil, G., & Heidenreich, O. T. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02259.x · Cited by 9
Pritchard‐Jones, K. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011578 · Cited by 9
Yoshida, T., Yamasaki, K., Tadagaki, K., Kuwahara, Y., Matsumoto, A., Sofovic, A., Kondo, N., Sakai, T., & Okuda, T. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5296 · Cited by 9
Genetic Markers in Sporadic Tumors
Tamborini, E., Perrone, F., Frattini, M., Negri, T., Aiello, A., Gloghini, A., Carbone, A., Pilotti, S., & Pierotti, M. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_3 · Cited by 8
Kugler, E., Madiwale, S., Yong, D., Thoms, J. A. I., Birger, Y., Sykes, D. B., Schmoellerl, J., Drakul, A., Priebe, V., Yassin, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41067-2 · Cited by 8
Mutational Analyses of the AML1 Gene in Patients with Myelodysplastic Syndrome
Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K., & Hirai, H. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290012155 · Cited by 7
Nakata, T., Kitamura, Y., Shimizu, K., Tanaka, S., Fujimori, M., Yokoyama, S., Ito, K., & Emi, M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199906)25:2 · Cited by 134
Mechanism of Transcriptional Repression by TEL/RUNX1 Fusion Protein
Lee, Y. J., Kim, J. H., Bae, S., Rho, S.-K., & Choe, S. Y. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13029-9 · Cited by 7
Tsukamoto, N., Karasawa, M., Tanaka, Y., Yokohama, A., Uchiumi, H., Matsushima, T., Murakami, H., & Nojima, Y. (2003) · International Journal of Hematology · doi:10.1007/bf02983563 · Cited by 6
Genetic analysis of 8;21 chromosomal translocation without AML1 gene involvement in MDS‐AML
Kawano, S., Miyanishi, S., Shimizu, K., Tanaka, K. J., Okumura, A., Ohki, M., Kamada, N., & Ohno, Y. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4593264.x · Cited by 6
10 Factors involved in leukaemogenesis and haemopoiesis
Elefanty, A. G., Robb, L. G., & Begley, C. G. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80028-5 · Cited by 6
A role for cadherins in cellular signaling and differentiation
Knudsen, K. A., Frankowski, C., Johnson, K. R., & Wheelock, M. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+ · Cited by 88
Jakubowiak, A. J., Cammenga, J., Sokolic, R. A., Álvarez, S., Jackson, G., Hedvat, C. V., & Nimer, S. D. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0083-z · Cited by 6
C11orf21, a novel RUNX1 target gene, is down-regulated by RUNX1-ETO
Matsumoto, A., Yoshida, T., Shima, T., Yamasaki, K., Tadagaki, K., Kondo, N., Kuwahara, Y., Zhang, D., & Okuda, T. (2022) · BBA Advances · doi:10.1016/j.bbadva.2022.100047 · Cited by 5
Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis
Peterson, L. F., Lo, M., Okumura, A. J., & Zhang, D. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.012 · Cited by 6
Leukemias, Lymphomas, and Other Related Disorders
Zhang, Y., & Rowley, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00079-3 · Cited by 5
Kozu, T., Sugio, Y., Fukuyama, T., Sueoka, E., Otsuka, T., & Akagi, K. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00353.x · Cited by 5
Hematopoietic Growth Factors in Leukemia
Touw, I. P., & Dong, F. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80095-1 · Cited by 5
Moon, Y., Horsman, D. E., Humphries, R. K., & Park, G. (2013) · Immune Network · doi:10.4110/in.2013.13.5.222 · Cited by 4
Dominant Negative Effects of the AML1/ETO Fusion Oncoprotein
Fenske, T. S., Pengue, G., & Graubert, T. A. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1399 · Cited by 4
AML1 and AML1 Fusion Protein AML1-ETO in Myeloid Gene Regulation and Leukemogenesis
Zhang, D., Burel, S. A., Zhou, L., Hetherington, C. J., & Yuan, Y. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0391 · Cited by 4
Transforming Properties of the Leukemic Inv(16) Fusion Gene CBFB-MYH11
Hajra, A. K., Liu, P. P., & Collins, F. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_29 · Cited by 4
Clinical Significance of Cytogenetics in Acute Leukemias
Shah, J., Karl Theil, M., & Kalaycio, M. E. (2003) · Laboratory Medicine · doi:10.1309/03cv-n1jh-4da0-8m5m · Cited by 4
Stein, G. S., Lian, J. B., Stein, J. L., van Wijnen, A. J., Montecino, M. A., Javed, A., Pratap, J., Choi, J. Y., Zaidi, S. K., Gutierrez, S. E., et al. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10364 · Cited by 3
New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins
Li, J., Guo, C. H., Steinauer, N., & Zhang, J. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1415-1 · Cited by 3
De novo Acute Myelogenous Leukemia with Trilineage Myelodysplasia Associated with t(8;21)(q22;q22).
Fujisawa, S., Togawa, J.-I., Tanaka, M., Koharazawa, H., Aoba, M., Fujita, H., MURATA, T., Kanamori, H., Matsuzaki, M., Mohri, H., et al. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.607 · Cited by 3
Stein, G. S., Lian, J. B., Stein, J. L., van Wijnen, A. J., Javed, A., Zaidi, S. K., Shen, J., Pockwinse, S. M., Young, D. W., Montecino, M. A., et al. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50022-x · Cited by 3
The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival
Dhir, A., Ethell, A., Watkins, R., Lam, C. K., Tur-Rodriguez, K., Persinger, J., Dobish, K. K., Panda, S., Buckley, S. M., Swenson, S. A., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02799-w · Cited by 3
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Singh, S. M., Trivedi, A. K., Lochab, S., Christopeit, M., Hiddemann, W., & Behre, G. (2010) · Clinical Proteomics · doi:10.1007/s12014-010-9051-2 · Cited by 2
Cytogenetic and Molecular Genetic Changes in Childhood Acute Leukaemias
Niini, T. (2002) · Työväentutkimus Vuosikirja · Cited by 2
The molecular basis of children's cancers
Anderson, J., & Pritchard‐Jones, K. (2004) · CRC Press eBooks · doi:10.1201/b13276-4 · Cited by 2
Transcription Factors Responsible for Megakaryocyte-specific Gene Expression
Doi, T. (2005) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.125.685 · Cited by 2
Pavlović, S., & Tos̆ić, N. (2019) · Europeanization and globalization · doi:10.1007/978-3-030-16465-2_28 · Cited by 1
Non-Androgen Regulated Transcription Factors as Novel Potential Targets for Prostate Cancer Therapy
Nathan, J., Adam, H., Yong, T., & Meyers, S. (2013) · InTech eBooks · doi:10.5772/53090 · Cited by 1
Self-citationIdentification and characterization of the T-cell-specific enhancer of type B leukemogenic virus
Mertz, J. A. (2003) · Texas ScholarWorks (Texas Digital Library) · Cited by 1
Genetic Markers in Sporadic Tumors
Aiello, A., Tamborini, E., Frattini, M., Perrone, F., Oggionni, M., Pilotti, S., & Pierotti, M. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_3 · Cited by 1
Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins
Wolyniec, K. (2008) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.578
Characterisation of the leukaemia-associated ETO homologues
Lindberg, S. R. (2006) · Lund University Publications (Lund University)
The role of the leukemia-associated ETO homologue repressors in hematopoiesis
Olsson, A. (2006) · Lund University Publications (Lund University)
Aberrant Transcription Factors in AML
Friedman, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_2
Redirection of Oncoproteins to Kill Cancer Cells
Müller‐Tidow, C., Steffen, B., Berdel, W. E., & Serve, H. L. (2003) · Cell Cycle · doi:10.4161/cc.2.6.585
Study of molecular mechanisms implicated in the TGF-beta oncogenic effect in Glioma
Juncà, A. G. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Common Leukemic Fusions in Pathogenesis and in Treatment Response in Acute Myeloid Leukemia
Fufan, T., Ahmed, S., & Persson, J. L. (2010) · The Open Leukemia Journal · doi:10.2174/1876816401003010001
Functional characterization of the nucleoporin CAN and CAN-derived leukemia-specific fusion proteins
Boer, J. M. (1997) · EUR Research Repository (Erasmus University Rotterdam)
Hiebert, S. W., Lutterbach, B. A., Amann, J. M., Durst, K. L., & Linggi, B. E. (2003) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-59358-1_6
Self-citationFonatsch, C., Schwarzinger, I., Mitterbauer, G., Jaeger, U., Wieser, R., Mannhalter, C., & Lechner, K. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_10
The role of Hoxb8 in myeloid progenitor cell immortalisation
Salmanidis, M. (2013) · Minerva Access (University of Melbourne)
Pargmann, D. (2006) · DuEPublico (University of Duisburg-Essen)
Studies on the core binding factor complex in patients with acute myeloid leukaemia
Langabeer, S. E. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique)
Nanan, K. K. (2014) · QSpace (Queen's University Library)
Leukemias, Lymphomas, and Plasma Cell Disorders
Morrissette, J. J. D., Roth, J. J., Luger, S. M., & Stadtmauer, E. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00012-6
Genetic Markers in Sporadic Tumors
Birindelli, S., Aiello, A., Lavarino, C., Sozzi, G., Pilotti, S., & Pierotti, M. A. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_3 · Cited by 3
Targeting Oncogenes in Pediatric Malignancies
Klement, G. L., & Kerbel, R. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-313-2_19
Labelle, Y., & Delattre, O. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_3
Cooperating Events in Core Binding Factor Leukemia Development: A Dissertation
Madera, D. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/k9gj-gr76
Chan, I. T., & Gilliland, D. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_79
Metadata
- Authors
- Meyers, S., Lenny, N., & Hiebert, S. W.
- Affiliations
- St. Jude Children's Research Hospital (US)
- ORCID
- Hiebert, Scott W.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1995-04-01
- Volume
- 15
- Issue
- 4
- Pages
- 1974-1982
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC230424
- OpenAlex
- W2113086962
- Cited by
- 368
- References
- 46
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 4 · 2013: 11 · 2012: 3
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lebanese Syrian Associated Charities
- National Institutes of Health
- National Cancer Institute (R01CA064140, P30CA021765)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- ETO, CBFβ, acute myeloid leukemia, transcriptional activation, alternative splicing, DNA-binding domain, nuclear localization, chromosomal translocation
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, Amino Acid Sequence, Base Sequence, Cell Compartmentation, Cell Nucleus, Cloning, Molecular, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Molecular Sequence Data, Neoplasm Proteins, Protein Binding, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transcription Factors, Transcription, Genetic, Leukemia, Myeloid, Acute, Transcriptional Activation, Consensus Sequence, Alternative Splicing, DNA, Complementary, Core Binding Factors, Core Binding Factor Alpha 2 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review